Risk of Serious Infection in Patients Receiving Systemic Medications for the Treatment of Psoriasis

Abstract

Among patients with psoriasis treated with systemic medications in 2 large US claims databases, new users of apremilast, etanercept, and ustekinumab had a decreased rate of serious infection compared with methotrexate.